Table 3.
Before PSM | After PSM | |||||
---|---|---|---|---|---|---|
Early PCI | Delayed PCI | P Value | Early PCI | Delayed PCI | P Value | |
Variables | n = 7705 | n = 3946 | n = 3708 | n = 3708 | ||
Age, y, median (IQR) | 73 (64–80) | 73 (65–81) | 0.003 | 74 (65–81) | 73 (65–81) | 0.26 |
Caucasian, % | 70.7 | 72.5 | <0.001 | 73.1 | 72.1 | 0.76 |
Weekend admission, % | 17.0 | 34.9 | <0.001 | 30.6 | 30.9 | 0.76 |
Female sex, % | 35.5 | 37.1 | 0.1 | 37.7 | 36.9 | 0.49 |
Chronic pulmonary disease | 22.4 | 25.1 | 0.001 | 24.8 | 24.8 | 0.98 |
Coagulopathy | 4.9 | 5.3 | 0.26 | 5.4 | 5.3 | 0.84 |
Depression | 8.7 | 8.8 | 0.79 | 8.9 | 9.0 | 0.87 |
HTN | 88.6 | 88.2 | 0.52 | 87.9 | 88.3 | 0.64 |
Fluid and electrolyte disorders | 20.9 | 28.6 | <0.001 | 26.8 | 27.8 | 0.36 |
Acute CVA | 0.8 | 0.9 | 0.65 | 1.0 | 0.9 | 0.81 |
Obesity | 20.5 | 20.8 | 0.68 | 21.0 | 20.9 | 0.93 |
PVD | 20.9 | 22.3 | 0.08 | 21.7 | 22.0 | 0.76 |
DM | 57.0 | 59.9 | 0.003 | 59.1 | 59.5 | 0.74 |
Prior MI | 19.5 | 19.4 | 0.9 | 18.2 | 19.3 | 0.25 |
Smoking | 34.0 | 33.2 | 0.39 | 34.1 | 33.3 | 0.46 |
Dyslipidemia | 76.8 | 73.4 | <0.001 | 72.9 | 74.1 | 0.23 |
Prior revascularization | 33.8 | 34.1 | 0.76 | 33.3 | 33.8 | 0.59 |
Chronic ASA use | 19.8 | 19.5 | 0.68 | 19.9 | 19.6 | 0.75 |
Family history of CAD | 8.1 | 7.6 | 0.39 | 7.6 | 7.6 | 1.00 |
Ventricular arrhythmia | 4.7 | 5.0 | 0.54 | 5.1 | 4.8 | 0.56 |
Cardiogenic shock | 3.3 | 2.1 | <0.001 | 2.2 | 2.1 | 0.81 |
AKI | 31.8 | 39.9 | <0.001 | 39.3 | 38.6 | 0.52 |
Year | ||||||
2010 | 14.2 | 13.5 | 0.34 | 13.5 | 13.3 | 0.84 |
2011 | 19.1 | 18.4 | 18.9 | 18.6 | ||
2012 | 20.6 | 21.3 | 20.7 | 21.5 | ||
2013 | 22.6 | 23.6 | 22.7 | 23.5 | ||
2014 | 23.5 | 23.2 | 24.2 | 23.1 |
Abbreviations: AKI, acute kidney injury; ASA, acetylsalicylic acid (aspirin); CAD, coronary artery disease; CVA, cerebrovascular accident; DM, diabetes mellitus; HTN, hypertension; IQR, interquartile range; MI, myocardial infarction; PCI, percutaneous coronary intervention; PSM, propensity score matching; PVD, peripheral vascular disease.